Forecasting the future for patients with hereditary TTP

Blood

Volumn 120, Issue 2, 2012, Pages 243-244

  George, James N ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ENZYME ACTIVITY; EXCHANGE BLOOD TRANSFUSION; FORECASTING; GENE MUTATION; GENETIC DISORDER; HEMOLYSIS; HEMOPHILIA; HEREDITARY ELLIPTOCYTOSIS; HEREDITARY THROMBOTIC THROMBOCYTOPENIC PURPURA; HUMAN; NOTE; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 84864136026     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-05-427419     Document Type: Note

References (11)

1. Schulman I, Pierce M, Lukens A, Currimbhoy Z. Studies on thrombopoiesis: I. A factor in normal plasma required for platelet production: chronic thrombocytopenia due to its deficiency. Blood. 1960;16(1):943-957.
2. Upshaw JD Jr. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. N Engl J Med. 1978;298(24):1350-1352.
3. Moake JL, Rudy CK, Troll JH, et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982;307(23):1432-1435. (Pubitemid 13234018)
4. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89(9):3097-3103. (Pubitemid 27229791)
5. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413(6855):488-494. (Pubitemid 32938741)
6. Fujimura Y, Matsumoto M, Isonishi A, et al. Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan. J Thromb Haemost.2011;9(Suppl 1):283-301.
7. Lotta LA, Wu HM, Mackie IJ, et al. Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura. Blood. 2012;120(2):440-448.
8. Moatti-Cohen M, Garrec C, Wolf M, et al. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-associated thrombotic thrombocytopenic purpura [published online ahead of print April 30, 2012]. Blood. doi: 10.1182/blood-2012-02-408914.
9. Fuchs WE, George JN, Dotin LN, Sears DA. Thrombotic thrombocytopenic purpura. Occurrence two years apart during late pregnancy in two sisters. JAMA. 1976;235(19):2126.
10. George JN. Congenital thrombotic thrombocytopenic purpura: Lessons for recognition and management of rare syndromes. Pediatr Blood Cancer. 2008;50(5):947-948. (Pubitemid 351500168)
11. Gandhi C, Khan MM, Lentz SR, Chauhan AK. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. Blood. 2012;119(10):2385-2391.